Aldeyra Therapeutics Inc. (ALDX)
NASDAQ: ALDX
· Real-Time Price · USD
5.38
0.08 (1.51%)
At close: Aug 15, 2025, 3:47 PM
Aldeyra Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 244.53K | n/a | n/a | n/a | 392.62K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 62.28K | 60.91K | 122.26K | 62.99K | 61.63K | 60.63K | 66.47K | 65K | 64.34K | 66.97K | n/a | 65.31K | 64.01K | 62.74K | 61.27K | 68.35K | n/a | 67.86K |
Gross Profit | -62.28K | -60.91K | 122.26K | -62.99K | -61.63K | -60.63K | -66.47K | -65K | -64.34K | -66.97K | n/a | -65.31K | -64.01K | -62.74K | -61.27K | -68.35K | -66.69K | -67.86K |
Operating Income | -10,168.7B | -10.43M | -16.58M | -16.14M | -18.01M | -9.39M | -6.1M | -9.55M | -10.34M | -16.8M | -13.7M | -14.79M | -17.71M | -16.48M | -15.4M | -15.44M | -14.54M | -10.83M |
Interest Income | 872.04K | 981.49K | 1.24M | 1.5M | 1.64M | 1.81M | 1.86M | 1.9M | 1.88M | 1.68M | 1.25M | 648.24K | 344.38K | 101.38K | 62.63K | 59.31K | 39.66K | 23.76K |
Pretax Income | -9,767.3B | -9.93M | -15.81M | -15.11M | -16.85M | -8.08M | -4.75M | -8.19M | -8.99M | -15.62M | -12.9M | -14.55M | -17.78M | -16.79M | -15.76M | -15.79M | -14.94M | -11.29M |
Net Income | -9,767.3B | -9.93M | -15.81M | -15.11M | -16.85M | -8.08M | -4.75M | -8.19M | -8.99M | -14.92M | -12.9M | -14.32M | -17.85M | -17.09M | -15.76M | -15.79M | -14.94M | -11.29M |
Selling & General & Admin | 1,663.5B | 2.94M | 1.95M | 3.7M | 2.98M | 3.21M | 1.73M | 2.59M | 3.38M | 5.57M | 4.74M | 3.25M | 3.14M | 4.25M | 2.56M | 2.55M | 3.07M | 3.1M |
Research & Development | 8,505.2B | 7.42M | 14.63M | 12.44M | 14.97M | 6.18M | 4.3M | 6.96M | 6.96M | 11.24M | 8.96M | 11.54M | 14.57M | 12.23M | 12.84M | 12.89M | 11.47M | 7.73M |
Other Expenses | -10,168.7B | 61.46K | n/a | n/a | n/a | -492 | 66.78K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.11M | 10.43M | 16.58M | 16.14M | 17.95M | 9.39M | 6.1M | 9.55M | 10.34M | 16.8M | 13.7M | 14.79M | 17.71M | 16.48M | 15.4M | 15.44M | 14.54M | 10.83M |
Interest Expense | 470.62K | 483.53K | 470.86K | 479.25K | 477.6K | 498.53K | 514.26K | 538.74K | 527.14K | 491.29K | 460.82K | 416.92K | 410.39K | 405.97K | 412.94K | 413.11K | 433.48K | 482.58K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -61.63K | n/a | -66.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.17M | 10.43M | 16.58M | 16.14M | 18.01M | 9.39M | 6.1M | 9.55M | 10.34M | 16.8M | 13.7M | 14.79M | 17.71M | 16.48M | 15.4M | 15.44M | 14.54M | 10.83M |
Income Tax Expense | n/a | n/a | 3.00 | n/a | n/a | n/a | n/a | n/a | n/a | -696K | n/a | -231K | 66.02K | 304.58K | n/a | 59.31K | 39.66K | 23.76K |
Shares Outstanding (Basic) | 60.05M | 59.89M | 59.48M | 59.53M | 59.41M | 59.41M | 59.2M | 58.99M | 58.79M | 58.79M | 58.56M | 58.46M | 58.3M | 58.3M | 58.02M | 58.02M | 54.28M | 45.63M |
Shares Outstanding (Diluted) | 60.05M | 59.89M | 59.48M | 59.53M | 59.41M | 59.41M | 59.2M | 58.99M | 58.79M | 58.79M | 58.56M | 58.46M | 58.3M | 58.3M | 58.02M | 58.02M | 54.28M | 45.63M |
EPS (Basic) | -0.16 | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 | -0.08 | -0.14 | -0.15 | -0.25 | -0.22 | -0.24 | -0.31 | -0.29 | -0.27 | -0.27 | -0.28 | -0.25 |
EPS (Diluted) | -0.16 | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 | -0.08 | -0.14 | -0.15 | -0.25 | -0.22 | -0.24 | -0.31 | -0.29 | -0.27 | -0.27 | -0.28 | -0.25 |
EBITDA | -10,168.7B | -9.38M | -15.27M | -14.57M | -16.31M | -7.52M | -4.17M | -7.58M | -8.4M | -15.06M | -12.38M | -14.07M | -17.31M | -16.32M | -15.28M | -15.31M | -14.44M | -10.74M |
EBIT | -9.3M | -9.45M | -15.34M | -14.63M | -16.37M | -7.58M | -4.24M | -7.65M | -8.46M | -15.12M | -12.44M | -14.14M | -17.37M | -16.38M | -15.34M | -15.38M | -14.5M | -10.81M |
Depreciation & Amortization | 62.28K | 60.91K | 64.37K | 62.99K | 61.63K | 60.63K | 66.47K | 65K | 64.34K | 66.97K | 66.64K | 65.31K | 64.01K | 62.74K | 61.27K | 68.35K | 66.69K | 67.86K |